naftazone (cas 15687-37-3) reduces glutamate cerebro spinal fluid levels in rats and glutamate release from mouse cerebellum synaptosomes

Add time:09/03/2019    Source:sciencedirect.com

It is well known that an excessive release of glutamate in the mammalian brain plays a major role in several neurological diseases. naftazone (cas 15687-37-3) (Etioven®) is a currently used vasoprotectant drug that is metabolized in humans by reduction and glucuronidation. In the present study naftazone was found to decrease glutamate levels in the cerebro spinal fluid (CSF) of rats treated for 15 days, as determined by a chemiluminescent glutamate assay reaction. Naftazone and its glucuronide derivative also reduced respectively spontaneous and high K+-evoked glutamate release from mouse cerebellum synaptosomes. It is likely that naftazone and its glucuronide metabolite contribute in vivo to decrease glutamate levels in the CSF through their inhibitory actions on glutamate release.

We also recommend Trading Suppliers and Manufacturers of naftazone (cas 15687-37-3). Pls Click Website Link as below: cas 15687-37-3 suppliers

Prev:Analytical MethodsSimultaneous determination of clanobutin, dichlorvos, and naftazone (cas 15687-37-3) in pork, beef, chicken, milk, and egg using liquid chromatography-tandem mass spectrometry
Next:Fungal metabolite of naftazone (cas 15687-37-3) inhibits nitrite production by activated murine macrophages)